| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | PEN Penumbra Inc | Bose Arani57 | Director | Sell | 12,000 | $250.65 | $3,007,775.54 | -74.9% | +8.7% | - | |
| Aug 13, 2025 | ENOV Enovis Corp | Pryor Daniel A74 | EVP, Strategy &Business Dev. | Buy | 10,000 | $28.90 | $289,000.00 | +6.6% | +6.5% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Masoud Maher54 | President And CEO | Buy | 75,000 | $1.37 | $102,915.00 | +75.0% | +12.3% | - | |
| Aug 13, 2025 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Buy | 1,000 | $3.37 | $3,370.00 | +0.9% | +23.1% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Brooke William W | - | Buy | 50,000 | $1.29 | $64,500.00 | +49.6% | +12.3% | - | |
| Aug 13, 2025 | ESTA Establishment Labs Holdings Inc. | Lewin Nicholas Sheridan67 | Director | Buy | 2,300 | $34.30 | $78,879.65 | +16.2% | +78.5% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Swirsky Douglas J | Chief Financial Officer | Buy | 50,000 | $1.29 | $64,500.00 | +44.7% | +12.3% | - | |
| Aug 13, 2025 | MASI Masimo Corp | Brennan Michelle68 | Director, Chairman Of The Board | Buy | 200 | $152.80 | $30,560.00 | +1.4% | -6.0% | - | |
| Aug 12, 2025 | VMD Viemed Healthcare, Inc. | Moore Michael57 | President | Sell | 50,090 | $7.33 | $367,159.70 | -28.4% | -14.1% | - | |
| Aug 12, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 10,802 | $43.67 | $471,755.75 | -4.9% | +2.6% | - | |
| Aug 12, 2025 | PEN Penumbra Inc | Wilder Thomas57 | Director | Sell | 372 | $240.16 | $89,339.52 | -50.0% | +8.9% | - | |
| Aug 12, 2025 | IDXX Idexx Laboratories Inc /de | Erickson Michael G | Executive Vice President | Sell | 406 | $649.96 | $263,813.50 | -1.8% | +8.8% | - | |
| Aug 12, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J49 | President And CEO | Buy | 8,411 | $0.82 | $6,922.25 | - | +2.3% | - | |
| Aug 12, 2025 | LMAT Lemaitre Vascular Inc | Jasinski Lawrence J62 | Director | Sell | 976 | $92.78 | $90,553.28 | -17.0% | -7.0% | - | |
| Aug 12, 2025 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 2,000 | $4.81 | $9,620.00 | +7.2% | -28.1% | - | |
| Aug 12, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 23,356 | $43.01 | $1,004,609.58 | -6.2% | +2.6% | - | |
| Aug 12, 2025 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Sr Vice President, Sales | Buy | 1,056,064 | $0.04 | $42,242.56 | +8.1% | - | - | |
| Aug 11, 2025 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 1,000 | $4.23 | $4,230.00 | +0.3% | +44.3% | - | |
| Aug 11, 2025 | BLFS Biolife Solutions Inc | Casdin Partners Master Fund, L.P.54 | 10% Owner | Sell | 500,000 | $22.60 | $11,300,000.00 | -6.5% | +17.5% | - | |
| Aug 11, 2025 | IDXX Idexx Laboratories Inc /de | Hunt Nimrata66 | Executive Vice President | Sell | 1,200 | $656.53 | $787,840.20 | -6.7% | +8.8% | - | |
| Aug 11, 2025 | TNDM Tandem Diabetes Care Inc | Sheridan John F51 | President &CEO | Buy | 10,000 | $10.23 | $102,318.00 | +10.4% | +61.8% | - | |
| Aug 11, 2025 | IRTC Irhythm Holdings, Inc. | Talwalkar Abhijit Y56 | Director | Sell | 5,312 | $158.02 | $839,380.65 | -11.1% | +9.8% | - | |
| Aug 11, 2025 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Sr Vice President Of Sales | Buy | 500,000 | $0.04 | $19,500.00 | +6.5% | - | - | |
| Aug 11, 2025 | MASI Masimo Corp | Jellison William R48 | Director | Buy | 3,000 | $145.98 | $437,940.00 | +167.6% | -1.9% | - | |
| Aug 11, 2025 | IRTC Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | Sell | 226 | $158.93 | $35,918.18 | -2.0% | +9.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.